Al‐Alaiyan 1996.

Methods	Blinding of randomisation: yes Blinding of intervention: can't tell but probably impossible Complete follow‐up: yes Blinding of outcome measurement: can't tell
Participants	Term and premature infants, >36 weeks GA, >24 hours of age. Qualifying SBR 170‐300 (direct SBR <25). Haemolysis excluded. Fibreoptic n=15, conventional n=15.
Interventions	Fibreoptic: BiliBlanket at 22.34 microwatts/cm2/nm (measured). Conventional: Air‐Shields (white) at 11.6 microwatts/cm2/nm (measured).
Outcomes	Duration of phototherapy (no SBR level specified for cessation of phototherapy therefore not included). Absolute SBR at beginning and end of treatment.
Notes	Data complete
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment?	Low risk	A ‐ Adequate